LOW-VOLUME · HOSP-MID
molnupiravir Side Effects
molnupiravir (also sold as Lagevrio) is a LOW-VOLUME FAERS extract #393 of 524 by FAERS report count. Still opens on HOSP-MID: 18.2% mention hospitalization (933 reports).
Data updated 2026-05-15
- 5,119
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
molnupiravir: 18.2% mention hospitalization (933 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #393 of 524 by FAERS report count.
Thinner FAERS extract for molnupiravir (Lagevrio) (5,119 reports #393 of 524 by FAERS report count). 18.2% mention hospitalization (933 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2018–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
COVID-19 leads 476 of 5,119 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (1,840 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (472 reports, 9.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| COVID-19 | 131 |
| DEATH | 103 |
| PNEUMONIA ASPIRATION | 39 |
| PNEUMONIA | 34 |
| RESPIRATORY FAILURE | 29 |
| COVID-19 PNEUMONIA | 28 |
| DECREASED APPETITE | 25 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 20 |
| HAEMATEMESIS | 18 |
| NAUSEA | 18 |
| CARDIAC FAILURE | 16 |
| CARDIAC ARREST | 14 |
| DIARRHOEA | 14 |
| DYSPHAGIA | 14 |
| ABDOMINAL DISCOMFORT | 13 |
| CONDITION AGGRAVATED | 11 |
| MARASMUS | 11 |
| SEPSIS | 11 |
Reactions in Hospitalization Reports
Hospitalization mid-share (933, 18.2%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| COVID-19 | 258 |
| COVID-19 PNEUMONIA | 67 |
| PNEUMONIA | 58 |
| DIARRHOEA | 53 |
| ADVERSE EVENT | 46 |
| VOMITING | 40 |
| CONDITION AGGRAVATED | 34 |
| NAUSEA | 34 |
| OXYGEN SATURATION DECREASED | 32 |
| PYREXIA | 31 |
| DECREASED APPETITE | 30 |
| PNEUMONIA ASPIRATION | 30 |
| DYSPHAGIA | 24 |
| HOSPITALISATION | 22 |
| DEHYDRATION | 20 |
| ANAEMIA | 19 |
| DYSPNOEA | 19 |
How to read molnupiravir FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)
FAERS holds 5,119 voluntary reports linked to molnupiravir (Lagevrio), 2018-2025. Death is listed on 472 (9.2%). Hospitalization appears on 933 (18.2%). Top co-reported indication: Covid-19 Treatment.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with molnupiravir
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 5,207 FAERS cases (Δ 88 heavier vs molnupiravir); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 5,225 FAERS cases (Δ 106 heavier vs molnupiravir); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 5,230 FAERS cases (Δ 111 heavier vs molnupiravir); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 4,979 FAERS cases (Δ 140 lighter vs molnupiravir); DEATH-HEAVY · HOSP-HEAVY · MALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 52.9 pp vs molnupiravir's DEATH-HEAVY): CASELOAD · HOSP-MID.
molnupiravir stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.